Editas Medicine(us:EDIT)

    1.25

    -4.58%

    Updated on 2024-12-23

    Open:1.31
    Close:1.25
    High:1.34
    Low:1.25
    Pre Close:1.31
    Volume:2.03M
    Amount:2.59M
    Turnover:2.46%
    Shares:82.55M
    MarketCap:103.19M

    About Editas Medicine Company

    Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA.

    Company Name: Editas Medicine
    Company Address: 11 Hurley Street
    Employees: 265
    Fiscar Year: 12-31
    IPO Date: 2016-02-03
    CIK: 1650664

    View all SEC Filings

    About

    Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA.
    Address:11 Hurley Street
    Website:http://www.editasmedicine.com

    Market Movers